Dysphagia due to tardive dyskinesia

Bhat, Pookala Shivaram; Pardal, PK; Diwakar, Mithun

doi:10.4103/0972-6748.90347

Cited by 5 publications

(3 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Comparatively the atypical or second -generation antipsychotics (SGA) or also known as serotonin 5HT2 and dopamine D2 receptor antagonist was less frequent causing TD such as olanzapine, risperidone, aripiprazole, quetiapine, and clozapine was extremely rare and could diminish the tardive dyskinesia risk compared to the other drugs. 3,6,8,12 This patient had a history dysp of dysphagia after consuming psychotropic drugs more than 4 weeks, caused by mental stress and felt better after taking the drugs. Dysphagia due to taking antipsychotic drugs had been reported by Kadota et al 4 , Gregory et al 5 , Miaron et al 6 , and Bhat et al 7 The symptom of dysphagia clear up after discontinuation of the drugs.…”

Section: Improved Symptomsmentioning

confidence: 99%

Disfagia orofaringeal pada sindrome ekstrapiramidal

simanjuntak

Budiarti

Muyassaroh

2021

Oto Rhino Laryn Indones

View full text Add to dashboard Cite

ABSTRAKLatar Belakang: Disfagia dapat disebabkan oleh gangguan mekanik maupun motorik. Disfagia berhubungan dengan kelainan neurologis pada sindrome ektrapiramidal (SEP) antara lain tardive dyskinesia yang disebabkan pemakaian obat antipsikotik kronis jangka panjang. Disfagia pada SEP sekitar 9,4 % terjadi pada usia dewasa muda. Disfagia pada SEP dapat sebagai gejala tunggal atau sebagai gejala penyerta. Tujuan: Menggambarkan kasus disfagia orofaringeal pada SEP akibat efek obat antipsikotik yang dikelola secara multidisipliner. Kasus: Disfagia pada SEP, laki – laki 32 tahun dengan riwayat pemakaian chlorpromazine jangka panjang. Didapatkan tanda gejala SEP. Diagnostik disfagia orofaringeal dengan pemeriksaan FEES. Dilakukan terapi penelanan dan penggantian jenis obat Metode: Penelusuran kepustakaan 88 jurnal, terdapat 4 jurnal yang relevan. Hasil: Empat jurnal yang relevan menyatakan tatalaksana disfagia dengan SEP dilakukan penghentian obat antipsikotik tipikal. Kesimpulan : Disfagia pada SEP akibat penggunaan chorpromazine memberikan respon baik setelah dilakukan penggantian obat.Kata kunci: disfagia orofaringeal, sindrome ekstrapiramidal, chlorpromazine

show abstract

Section: Improved Symptomsmentioning

confidence: 99%

Disfagia orofaringeal pada sindrome ekstrapiramidal

simanjuntak

Budiarti

Muyassaroh

2021

Oto Rhino Laryn Indones

View full text Add to dashboard Cite

show abstract

“…In the case reports, some acknowledged ''self-report'' (Bhat et al, 2010, Chen et al, 2015, Crouse et al, 2017 but without further detail of the patient perspective. There was variation in the brief reporting of patient concerns, with the majority of descriptions reflecting patient complaints of swallowing difficulty (Bhat et al, 2010, Crouse et al, 2017, Duggal and Mendhekar, 2008, Dziewas et al, 2007, Lin et al, 2012, Nieves et al, 2007, Osman and Devadas, 2016, Varghese et al, 2006, or feeling unable to eat (Cicala et al, 2019, Lin et al, 2012. Other accounts suggested patient complaints of sialorrhea (Osman andDevadas, 2016, Sagar et al, 2005), and concerns regarding tremor (Leopold, 1996).…”

Section: Self Report Not Elaboratedmentioning

confidence: 99%

“…Three studies described how swallowing concerns expressed by patients informed dysphagia assessment (Aldridge and Taylor, 2012, Chen et al, 2015, Regan et al, 2006. Options for further clinician led investigations were advocated including instrumental assessment (Bazemore et al, 1991, Cicala et al, 2019, Dziewas et al, 2007, Sico and Patwa, 2011 and reviews of medication (Armstrong et al, 2008, Bhat et al, 2010, Cicala et al, 2019, Corcoran and Walsh, 2003, Crouse et al, 2017, Duggal and Mendhekar, 2008, Dziewas et al, 2007, Fioritti et al, 1997, Gregory et al, 1992, Hemsley et al, 2019, Hwang et al, 2010, Kulkarni et al, 2017, Leopold, 1996, McManus, 2001, Mendhekar and Agarwal, 2010, Osman and Devadas, 2016, Sagar et al, 2005, Sico and Patwa, 2011, Tang and Hsieh, 2010, Varghese et al, 2006. Duggal and Mendhekar (2008)p161 advised however that clinicians should "curtail extensive diagnostic testing and unfruitful medication trials"' and that review of medication should be prioritised.…”

Section: Clinician's Perspective On Assessment and Interventionmentioning

confidence: 99%

Mealtime difficulties in adults with mental health conditions: an integrative review

Guthrie

Baker

Cahill

et al. 2022

Journal of Mental Health

View full text Add to dashboard Cite

Background: Dysphagia and choking are highly prevalent in adults with mental health conditions. However, there is scant research considering the personal experience of dysphagia for this population.Aims: to understand the evidence-base for strategies to involve the patient in recognition, assessment and treatment of mealtime difficulties Methods: this integrative review synthesised the literature on the experience of dysphagia in patients with mental health conditions. Patient consultation led to co-designed search terms and eligibility criteria for a systematic search of five scientific databases following Prisma guidance. Quality assessment of the eligible studies and reflexive thematic analysis were completed.Results: 31 studies were included for review. These included case reports, literature reviews and cross-sectional studies. Quality of evidence was weak and no intervention studies were identified. There was scant detail regarding the personal experience of dysphagia or choking.Themes identified related to biomedical perspectives, influencing factors presented without context, and decision-making led by clinicians.Conclusions: guidance on mental healthcare calls attention to under-diagnosis of physical co-morbidities and advocates patient inclusion. However, the patient voice in this population is rarely described regarding dysphagia. Further inclusive research is indicated to explore the impact of dysphagia and choking, and implications for interventions and outcome measures 2

show abstract

Swallowing Disorders in Schizophrenia

2017

View full text Add to dashboard Cite

Disorders of swallowing are poorly characterized but quite common in schizophrenia. They are a source of considerable morbidity and mortality in this population, generally as a result of either acute asphyxia from airway obstruction or more insidious aspiration and pneumonia. The death rate from acute asphyxia may be as high as one hundred times that of the general population. Most swallowing disorders in schizophrenia seem to fall into one of two categories, changes in eating and swallowing due to the illness itself and changes related to psychotropic medications. Behavioral changes related to the illness are poorly understood and often involve eating too quickly or taking inappropriately large boluses of food. Iatrogenic problems are mostly related to drug-induced extrapyramidal side effects, including drug-induced parkinsonism, dystonia, and tardive dyskinesia, but may also include xerostomia, sialorrhea, and changes related to sedation. This paper will provide an overview of common swallowing problems encountered in patients with schizophrenia, their pathophysiology, and management. While there is a scarcity of quality evidence in the literature, a thorough history and examination will generally elucidate the predominant problem or problems, often leading to effective management strategies.

show abstract

Dysphagia due to tardive dyskinesia

Cited by 5 publications

References 8 publications

Disfagia orofaringeal pada sindrome ekstrapiramidal

Disfagia orofaringeal pada sindrome ekstrapiramidal

Mealtime difficulties in adults with mental health conditions: an integrative review

Swallowing Disorders in Schizophrenia

Contact Info

Product

Resources

About